Suppr超能文献

随机尿标本中微量白蛋白尿筛查试验的效果如何?

How effective are screening tests for microalbuminuria in random urine specimens?

作者信息

Lum G

机构信息

Pathology and Laboratory Medicine Service, Veterans Affairs Boston Healthcare System, and Harvard Medical School, Boston 02132, USA.

出版信息

Ann Clin Lab Sci. 2000 Oct;30(4):406-11.

Abstract

The effectiveness of four urine screening tests-microalbumin (MAlb), total protein (TProt), total protein/creatinine ratio (TProt/Cr R), and dipstick (DPalb) test for albumin-were evaluated for the detection of MAlb in random urine specimens. The following criteria were used to assess the effectiveness of each urine screening test: 100% specificity (no false positive results); cost effectiveness; rapidity and ease of performing the screening test; and increased laboratory efficiency. A "gold standard" for presence of MAlb in random urine samples was defined as a microalbumin/creatinine ratio (MAlb/Cr R) of > or = 30 mg/g. The least costly urine screening test was the DPalb, which, if assigned a value of 1.0, allowed a cost ranking order for the screening tests-DPalb (1.0) < urine TProt (1.03) < urine TProt/Cr R (2.1) < urine MAlb (7.0). Two hundred urine samples from diabetic inpatients and outpatients were tested. Only two screening tests--MAlb and DPalb--achieved 100% specificity without increasing laboratory costs (small net savings), whereas the other two screening tests--TProt and TProt/Cr R-only achieved 100% specificity with increased laboratory costs. Theoretical prevalence rate analysis showed that urine MAlb screening would be effective at all prevalence rates for overt nephropathy. TProt and DPalb urine screening testing would be most effective in populations with prevalence rates of > or = 15% for overt nephropathy. The TProt/Cr R ratio would only be effective in populations with prevalence rates of > or = 30%. Of the four urine screening tests, only DPalb would significantly streamline the process of measuring urine MAlb. The dipstick test is inexpensive, easy and rapid to perform, does not delay measuring the ratio, since there is no wait for the screening test result, and can be used by referring laboratories to screen urine specimens before they are submitted to a central laboratory, thereby reducing laboratory workload.

摘要

对四种尿液筛查试验——微量白蛋白(MAlb)、总蛋白(TProt)、总蛋白/肌酐比值(TProt/Cr R)以及白蛋白试纸法(DPalb)检测白蛋白——在随机尿液标本中检测微量白蛋白的有效性进行了评估。采用以下标准评估每种尿液筛查试验的有效性:100%特异性(无假阳性结果);成本效益;筛查试验操作的快速性和简便性;以及提高实验室效率。随机尿液样本中微量白蛋白存在的“金标准”定义为微量白蛋白/肌酐比值(MAlb/Cr R)≥30 mg/g。成本最低的尿液筛查试验是DPalb,如果将其赋值为1.0,则筛查试验的成本排序为——DPalb(1.0)<尿液TProt(1.03)<尿液TProt/Cr R(2.1)<尿液MAlb(7.0)。对200例糖尿病住院患者和门诊患者的尿液样本进行了检测。只有两种筛查试验——MAlb和DPalb——在不增加实验室成本的情况下(略有净节省)达到了100%特异性,而另外两种筛查试验——TProt和TProt/Cr R——只有在增加实验室成本的情况下才达到100%特异性。理论患病率分析表明,尿液MAlb筛查在显性肾病的所有患病率下均有效。TProt和DPalb尿液筛查试验在显性肾病患病率≥15%的人群中最有效。TProt/Cr R比值仅在患病率≥30%的人群中有效。在这四种尿液筛查试验中,只有DPalb能显著简化测量尿液MAlb的过程。试纸法检测成本低廉、操作简便快捷,不会延迟比值测量,因为无需等待筛查试验结果,参考实验室可在将尿液标本提交至中心实验室之前使用该方法进行筛查,从而减轻实验室工作量。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验